Genomics in Cancer Care Market By Technology (Next-Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In Situ Hybridization), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer), By Application (Diagnostic Testing, Prognostic Testing, Treatment Selection, Monitoring Response to Therapy), By Sample Type (Blood, Tissue, Urine), By Clinical Setting (Hospital-Based Laboratories, Commercial Laboratories, Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Technology

• Next-Generation Sequencing
• Comparative Genomic Hybridization
• Fluorescence In Situ Hybridization

By Cancer Type

• Breast Cancer
• Lung Cancer
• Colorectal Cancer

By Application

• Diagnostic Testing
• Prognostic Testing
• Treatment Selection
• Monitoring Response to Therapy

By Sample Type

• Blood

• Tissue
• Urine

By Clinical Setting

• Hospital-based laboratories
• Commercial Laboratories
• Research Institutions

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• BGI Genomics Co., Ltd.
• Agilent Technologies, Inc.
• Qiagen N.V.
• Pacific Biosciences of California, Inc.
• 10x Genomics, Inc.
• Genewiz, Inc.
• Macrogen, Inc.
• Oxford Nanopore Technologies Ltd.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Quest Diagnostics Incorporated